Related Experiment Video
Updated: Jun 2, 2026

07:02
Trace Fear Conditioning in Mice
Published on: March 20, 2014
Catecholaminergic depletion in nucleus accumbens enhances trace conditioning
A J D Nelson1, K E Thur, C Spicer
1Institute of Neuroscience, Schools of Psychology, University of Nottingham, Nottingham, UK.
Advances in Medical Sciences
|April 26, 2011
Summary
Dopamine depletion in the nucleus accumbens core, not the shell, enhanced trace conditioning. This suggests the core plays a key role in this learning process.
Area of Science:
- Neuroscience
- Behavioral Neuroscience
- Neuropharmacology
Background:
- The nucleus accumbens is crucial for reward-based learning and motivation.
- Dopamine signaling within the nucleus accumbens modulates associative learning.
- The distinct roles of the nucleus accumbens core and shell sub-regions in conditioning remain incompletely understood.
Purpose of the Study:
- To investigate the impact of dopamine depletion in the nucleus accumbens on trace conditioning.
- To differentiate the specific contributions of the nucleus accumbens core versus shell sub-regions to trace conditioning.
Main Methods:
- Selective lesions of dopamine terminals in the nucleus accumbens core and shell were induced using 6-hydroxydopamine.
- Experiment 1 assessed trace conditioning using a tone conditioned stimulus and footshock unconditioned stimulus with a 30s trace interval.
- Experiment 2 evaluated contiguous conditioning (0s trace) with a light conditioned stimulus and footshock unconditioned stimulus.
Main Results:
- Lesions targeting the nucleus accumbens core abolished the typical reduction in conditioning seen with trace stimuli, enhancing conditioning instead.
- Shell-targeted lesions did not significantly alter trace conditioning compared to controls.
- Neither core nor shell lesions affected conditioning in the contiguous (0s trace) paradigm.
Conclusions:
- Dopamine depletion specifically within the nucleus accumbens core appears to mediate enhanced conditioning to trace stimuli.
- The findings suggest a critical role for the nucleus accumbens core in trace conditioning, distinct from the shell.
- While core dopamine depletion was linked to behavioral changes, potential involvement of affected shell regions or other brain areas cannot be ruled out.
More Related Videos
Related Concept Videos
Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...

